Dose-reduction trials in oncology - aiming for less toxicity and better quality of life at lower costs
Nat Rev Clin Oncol
.
2024 Feb;21(2):81-82.
doi: 10.1038/s41571-023-00831-5.
Authors
Kim Theilgaard-Mönch
1
2
3
,
Lars Holger Ehlers
4
Affiliations
1
Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. kim.theilgaard@bric.ku.dk.
2
Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. kim.theilgaard@bric.ku.dk.
3
Biotech Research and Innovation Centre, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. kim.theilgaard@bric.ku.dk.
4
Nordic Institute of Health Economics, Aarhus, Denmark.
PMID:
37845305
DOI:
10.1038/s41571-023-00831-5
No abstract available
MeSH terms
Humans
Medical Oncology
Neoplasms* / drug therapy
Quality of Life*